Detecting Amyloid-β Plaques in Alzheimer’s Disease

Methods in Molecular Biology

Volumn 711, Issue , 2011, Pages 511-533

  Baltes, Christof ^a   Princz Kranz, Felicitas ^a   Rudin, Markus ^a,b   Mueggler, Thomas ^c  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Alzheimer s disease (AD); amyloid precursor protein (APP); A plaques; Beta amyloid; contrast agent; histology; magnetic resonance imaging (MRI); MRI contrast; radiofrequency (RF) coil

Indexed keywords

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL; ARTICLE; BRAIN; HUMAN; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PERFUSION; PHENOTYPE; RADIOFREQUENCY RADIATION; REPRODUCIBILITY; STEREOTACTIC PROCEDURE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; PERFUSION; PHENOTYPE; PLAQUE, AMYLOID; RADIO WAVES; REPRODUCIBILITY OF RESULTS; STEREOTAXIC TECHNIQUES;

EID: 79955658817     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-992-5_26     Document Type: Chapter

References (39)

1. Selkoe, D. J. Alzheimer’s disease: Genes, proteins, and therapy. Physiol Rev 2001;81: 741–766.
2. Klunk, W. E., Lopresti, B. J., Ikonomovic, M. D., Lefterov, I. M., Koldamova, R. P. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer’s disease brain but not in transgenic mouse brain. J Neurosci 2005;25: 10598–10606.
3. Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C. et al. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease. Nature 2008;451(7179):720–724.
4. Guentert, A., Doebeli, H., Bohrmann, B. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Neuroscience 2006;143:461–475.
5. Kuo, Y. M., Kokjohn, T. A., Beach, T. G. et al. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer’s disease brains. J Biol Chem 2001;276: 12991–12998.
6. Connor, J. R., Menzies, S. L., St. Martin, S. M., Mufson, E. J. A histochemical study of iron, transferrin and ferritin in Alzheimer’s diseased brains. J Neurosci Res 1992;31: 75–83.
7. Meadowcroft, M. D., Connor, J. R., Smith, M. B., Yang, Q. X. MRI and histological analysis of Beta-Amyloid Plaques in both human Alzheimer’s disease and APP/PS1 transgenic mice. J Magn Reson Imaging 2009;29:997–1007.
8. Benveniste, H., Einstein, G., Kim, K. R., Hulette, C., Johnson, G. A. Detection of neuritic plaques in Alzheimer’s disease by magnetic resonance microscopy. Proc Natl Acad Sci USA 1999;96:14079.
9. ∗-weighted MR microscopic images. NMR Biomed 2002;15:197–203.
10. Poduslo, J. F., Wengenack, T. M., Curran, G. L. et al. Molecular targeting of Alzheimer’s amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 2002;11:315–329.
11. Rudin, M., Mueggler, T., Allegrini, P. R., Baumann, D., Rausch, M. Characterization of CNS disorders and evaluation of therapy using structural and functional MRI. Anal Bioanal Chem 2003;377:973–981.
12. Helpern, J. A., Lee, S. P., Falangola, M. F. et al. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer’s disease. Magn Reson Med 2004;51(4):794–798.
13. Lee, S. P., Falangola, M. F., Nixon, R. A., Duff, K., Helpern, J. A. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer’s disease using MR microscopy without contrast reagents. Magn Reson Med 2004;52:538–544.
14. Zhang, J., Yarowsky, P., Gordon, M. N. et al. Detection of amyloid plaques in mouse models of Alzheimer’s disease by magnetic resonance imaging. Magn Reson Med 2004;51:452–457.
15. Jack, C. R., Jr, Garwood, M., Wengenack, T. M. et al. In vivo visualization of Alzheimer’s amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 2004;52:1263–1271.
16. Vanhoutte, G., Dewachter, I., Borghgraef, P., Van Leuven, F., Van der Linden, A. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer’s disease. Magn Reson Med 2005;53(3):607–613.
17. Jack, C. R., Jr, Wengenack, T. M., Reyes, D. A. et al. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer’s transgenic mice. J Neurosci 2005;25(43):10041–10048.
18. Jack, C. R., Jr, Marjanska, M., Wengenack, T. M. et al. Magnetic resonance imaging of Alzheimer’s pathology in the brains of living transgenic mice: A new tool in Alzheimer’s disease research. Neuroscientist 2007;13(1):38–48.
19. Wadghiri, Y. Z., Sigurdsson, E. M., Sad-owski, M. et al. Detection of Alzheimer’s amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003;50:293–302.
20. Higuchi, M., Iwata, N., Matsuba, Y., Sato, K., Sasamoto, K., Saido, T. C. 19F and 1H MRI detection of amyloid b plaques in vivo. Nat Neurosci 2005;8:527–533.
21. Higgins, G. A., Jacobsen, H. Transgenic mouse models of Alzheimer’s disease: Phenotype and application. Behav Pharmacol 2003;14:419–438.
22. Ramakrishnan, M., Wengenack, T. M., Kandimalla, K. K., Poduslo, J. F. et al. Selective contrast enhancement of individual Alzheimer’s disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging. Pharm Res 2008;25(8):1861–1872.
23. Wengenack, T. M., Jack, C. R., Jr., Garwood, M., Poduslo, J. F. MR microimaging of amyloid plaques in Alzheimer’s disease transgenic mice. Eur J Nucl Med Mol Imaging 2008;35(Suppl 1):S82–S88.
24. Poduslo, J. F., Ramakrishnan, M., Holasek, S. S. et al. In vivo targeting of antibody fragments to the nervous system for Alzheimer’s disease immunotherapy and molecular imaging of amyloid plaques. J Neurochem 2007;102(2):420–433.
25. Braakman, N., Matysik, J., van Duinen, S. G. et al. Longitudinal assessment of Alzheimer’s β-Amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 2006;24:530–536.
26. Meadowcroft, M. D., Zhang, S., Liu, W. et al. Direct magnetic resonance imaging of histological tissue samples at 3.0T. Magn Reson Med 2007;57:835–841.
27. Hildebrandt, I. J., Su, H., Weber, W. A. Anesthesia and other considerations for in vivo imaging of small animals. ILAR J 2008;49(1):17–26.
28. ∗ 2-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer’s disease. Magn Reson Med 2009;61: 1158–1164.
29. Paxinos, G., Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press; 2001.
30. Muskulus, M., Scheenstra, A. E. H., Braakman, N. et al. Prospects for early detection of Alzheimer’s disease from serial MR images in transgenic mouse models. Curr Alzheimer Res 2009;6:503–518.
31. Braak, H., Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239–259.
32. Sigurdsson, E. M. Histological staining of amyloid-beta in mouse brains. Methods Mol Biol 2005;299:299–308.
33. Baltes, C., Radzwill, N., Bosshard, S., Marek, D., Micro, R. M. MR imaging of the mouse brain using a novel 400 MHz cryo- genic quadrature RF probe. NMR Biomed 2009;22(8):834–842.
34. Games, D., Adams, D., Alessandrini, R. et al. Alzheimer-type neuropathology in transgenic mice over-expressing V717F beta-amyloid precursor protein. Nature 1995;373: 523–527.
35. Moechars, D., Dewachter, I., Lorent, K. et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 1999;274(10):6483–6492.
36. Hsiao, K., Chapman, P., Nilsen, S. et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 1996;274:99–102.
37. Sturchler-Pierrat, C., Abramowski, D., Duke, M. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 1997;94:13287–13292.
38. Holcomb, L., Gordon, M. N., Accelerated, Mc. G. E. Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998;4:97–100.
39. Richards, J. G., Higgins, G. A., Ouagazzal, A. M. et al. PS2APP transgenic mice, coex-pressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J Neurosci 2003;23:8989–9003.